Evidence map›Paper›PMID 24638888›Full record

ReviewSeminars in immunopathology2014

Ectoenzymes in leukocyte migration and their therapeutic potential.

Marko Salmi, Sirpa Jalkanen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Comparison ofContrast media & molecular imaging · 2017
    Article
  11. Review
  12. Article
  13. Article
  14. How leukocytes cross the vascular endothelium.Nature reviews. Immunology · 2015
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marko SalmiMediCity Research Laboratory, University of Turku, Tykistökatu 6 A, FIN-20520, Turku, Finland.
Sirpa Jalkanen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation causes or accompanies a huge variety of diseases. Migration of leukocytes from the blood into the tissues, in the tissues, and from the tissues to lymphatic vasculature is crucial in the formation and resolution of inflammatory infiltrates. In addition to classical adhesion and activation molecules, several other molecules are known to contribute to the leukocyte traffic. Several of them belong to ectoenzymes, which are cell surface molecules having catalytically active sites outside the cell. We will review here how several ectoenzymes present on leukocytes or endothelial cell surface function as adhesins and/or modulate the extravasation cascade through their enzymatic activities. Moreover, their therapeutic potential as immune modulators in different experimental inflammation models and in clinical trials will be discussed.

Indexed as

Adenosine TriphosphateADP-ribosyl CyclaseADP-ribosyl Cyclase 1AnimalsAntigens, CDCell Adhesion MoleculesCell MembraneCell MovementChemokinesExtracellular SpaceGPI-Linked ProteinsHumansImmune System DiseasesInflammationLeukocytesPeptide HydrolasesAdenosine TriphosphateADP-ribosyl CyclaseADP-ribosyl Cyclase 1ADP-ribosyl cyclase 2Antigens, CDCell Adhesion MoleculesChemokinesGPI-Linked ProteinsPeptide Hydrolases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.